Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peptidylprolyl Isomerase | 24 | 2020 | 97 | 3.130 |
Why?
|
Breast Neoplasms | 38 | 2024 | 20982 | 1.210 |
Why?
|
Breast | 7 | 2024 | 1964 | 0.940 |
Why?
|
Poly(ADP-ribose) Polymerases | 3 | 2024 | 426 | 0.920 |
Why?
|
BRCA1 Protein | 10 | 2022 | 1149 | 0.880 |
Why?
|
Cell Transformation, Neoplastic | 9 | 2016 | 2820 | 0.870 |
Why?
|
Infectious Mononucleosis | 2 | 2022 | 133 | 0.870 |
Why?
|
Phthalazines | 7 | 2022 | 383 | 0.780 |
Why?
|
Mammary Neoplasms, Experimental | 6 | 2024 | 506 | 0.730 |
Why?
|
Phosphatidylinositol 3-Kinases | 9 | 2024 | 2864 | 0.690 |
Why?
|
Ovarian Neoplasms | 6 | 2022 | 4872 | 0.650 |
Why?
|
Genes, BRCA1 | 3 | 2023 | 754 | 0.630 |
Why?
|
Cystadenocarcinoma, Serous | 2 | 2020 | 478 | 0.620 |
Why?
|
Testosterone | 4 | 2024 | 2472 | 0.610 |
Why?
|
Gene Fusion | 2 | 2019 | 355 | 0.580 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 17 | 2024 | 11733 | 0.580 |
Why?
|
Fructose-Bisphosphate Aldolase | 2 | 2020 | 43 | 0.570 |
Why?
|
Ketones | 3 | 2024 | 182 | 0.560 |
Why?
|
Furans | 3 | 2024 | 201 | 0.550 |
Why?
|
Ubiquitin | 2 | 2020 | 839 | 0.530 |
Why?
|
Nucleosides | 1 | 2016 | 130 | 0.510 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 614 | 0.500 |
Why?
|
Herpesvirus 4, Human | 2 | 2022 | 1076 | 0.490 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2021 | 5300 | 0.480 |
Why?
|
Tumor Suppressor Protein p53 | 7 | 2017 | 2915 | 0.470 |
Why?
|
Mammary Glands, Animal | 4 | 2017 | 272 | 0.450 |
Why?
|
DNA Damage | 5 | 2020 | 2442 | 0.440 |
Why?
|
Mammography | 1 | 2024 | 2430 | 0.430 |
Why?
|
Receptor, erbB-2 | 9 | 2021 | 2553 | 0.420 |
Why?
|
BRCA2 Protein | 4 | 2022 | 797 | 0.390 |
Why?
|
Neoplasms | 7 | 2024 | 22140 | 0.370 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2019 | 2455 | 0.370 |
Why?
|
Cell Line, Tumor | 17 | 2024 | 16952 | 0.360 |
Why?
|
Morpholines | 3 | 2019 | 581 | 0.350 |
Why?
|
Interleukin-8 | 1 | 2013 | 696 | 0.340 |
Why?
|
Aminopyridines | 3 | 2019 | 573 | 0.330 |
Why?
|
Piperazines | 5 | 2022 | 2522 | 0.330 |
Why?
|
Epithelial Cells | 5 | 2016 | 3671 | 0.320 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4107 | 0.310 |
Why?
|
Mutation | 13 | 2024 | 30002 | 0.300 |
Why?
|
Signal Transduction | 20 | 2024 | 23416 | 0.300 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2024 | 3592 | 0.280 |
Why?
|
Cyclin D1 | 4 | 2004 | 451 | 0.270 |
Why?
|
Protein Kinase Inhibitors | 4 | 2020 | 5662 | 0.230 |
Why?
|
Mice | 31 | 2024 | 81326 | 0.230 |
Why?
|
Mice, SCID | 4 | 2021 | 2621 | 0.230 |
Why?
|
Pyruvic Acid | 2 | 2022 | 203 | 0.220 |
Why?
|
Sex Reassignment Procedures | 1 | 2024 | 70 | 0.220 |
Why?
|
Female | 57 | 2024 | 392544 | 0.220 |
Why?
|
Mitosis | 6 | 2024 | 1186 | 0.220 |
Why?
|
Pentose Phosphate Pathway | 2 | 2021 | 126 | 0.210 |
Why?
|
Humans | 83 | 2024 | 761208 | 0.210 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 2 | 2016 | 433 | 0.210 |
Why?
|
Receptors, Estrogen | 6 | 2023 | 2208 | 0.210 |
Why?
|
Animals | 39 | 2024 | 168079 | 0.200 |
Why?
|
Cell Division | 2 | 2009 | 4451 | 0.200 |
Why?
|
Mice, Inbred NOD | 2 | 2016 | 1822 | 0.190 |
Why?
|
Cell Cycle | 5 | 2024 | 2925 | 0.190 |
Why?
|
Phosphorylation | 14 | 2024 | 8300 | 0.190 |
Why?
|
Adenosine Diphosphate | 1 | 2022 | 422 | 0.190 |
Why?
|
Phosphogluconate Dehydrogenase | 1 | 2021 | 22 | 0.190 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2021 | 1892 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2020 | 8530 | 0.180 |
Why?
|
Nipples | 1 | 2023 | 229 | 0.180 |
Why?
|
Gene Deletion | 3 | 2021 | 2658 | 0.180 |
Why?
|
Cell Differentiation | 7 | 2021 | 11509 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2001 | 286 | 0.180 |
Why?
|
Ear | 1 | 2001 | 172 | 0.180 |
Why?
|
Niacinamide | 1 | 2022 | 413 | 0.180 |
Why?
|
Cyclins | 1 | 2002 | 594 | 0.170 |
Why?
|
Cell Cycle Proteins | 3 | 2024 | 3446 | 0.170 |
Why?
|
Vincristine | 5 | 2020 | 1036 | 0.170 |
Why?
|
Retinal Dehydrogenase | 2 | 2011 | 78 | 0.170 |
Why?
|
Transcriptional Activation | 4 | 2015 | 1749 | 0.170 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2023 | 484 | 0.170 |
Why?
|
Cells, Cultured | 9 | 2020 | 18926 | 0.160 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2024 | 899 | 0.160 |
Why?
|
Reactive Oxygen Species | 3 | 2022 | 2138 | 0.160 |
Why?
|
Mice, Knockout | 11 | 2021 | 14392 | 0.160 |
Why?
|
Immunohistochemistry | 7 | 2019 | 11067 | 0.160 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2020 | 242 | 0.160 |
Why?
|
Tumor Cells, Cultured | 7 | 2020 | 6124 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2020 | 987 | 0.160 |
Why?
|
Prothrombin | 1 | 1999 | 192 | 0.150 |
Why?
|
NAD | 1 | 2022 | 612 | 0.150 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2023 | 4574 | 0.150 |
Why?
|
Factor V | 1 | 1999 | 168 | 0.150 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2020 | 411 | 0.150 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 326 | 0.150 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2019 | 430 | 0.150 |
Why?
|
Disease-Free Survival | 4 | 2017 | 6819 | 0.150 |
Why?
|
Isoenzymes | 3 | 2013 | 1682 | 0.140 |
Why?
|
Breast Diseases | 1 | 2020 | 443 | 0.140 |
Why?
|
Protons | 1 | 2022 | 1111 | 0.140 |
Why?
|
RNA Interference | 3 | 2016 | 2816 | 0.140 |
Why?
|
3' Untranslated Regions | 1 | 1999 | 514 | 0.140 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2019 | 287 | 0.130 |
Why?
|
Cell Proliferation | 6 | 2024 | 10422 | 0.130 |
Why?
|
Mammary Glands, Human | 1 | 2017 | 202 | 0.130 |
Why?
|
Carboplatin | 1 | 2019 | 793 | 0.130 |
Why?
|
Receptors, Complement 3d | 1 | 2016 | 117 | 0.130 |
Why?
|
Macrophages | 2 | 2022 | 5753 | 0.130 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2018 | 410 | 0.130 |
Why?
|
Glycolysis | 2 | 2020 | 836 | 0.130 |
Why?
|
Genes, Tumor Suppressor | 1 | 2020 | 1057 | 0.130 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9416 | 0.130 |
Why?
|
Ubiquitination | 1 | 2020 | 1005 | 0.130 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2016 | 126 | 0.130 |
Why?
|
Thiazoles | 2 | 2022 | 1517 | 0.120 |
Why?
|
Sirolimus | 3 | 2016 | 1540 | 0.120 |
Why?
|
MAP Kinase Signaling System | 3 | 2020 | 1480 | 0.120 |
Why?
|
Repressor Proteins | 3 | 2019 | 2974 | 0.120 |
Why?
|
Viral Matrix Proteins | 1 | 2016 | 193 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2017 | 3777 | 0.120 |
Why?
|
Microtubules | 2 | 2020 | 1071 | 0.120 |
Why?
|
Cytomegalovirus | 1 | 2019 | 750 | 0.120 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2021 | 943 | 0.120 |
Why?
|
Catalysis | 3 | 2006 | 763 | 0.120 |
Why?
|
Centrosome | 2 | 2006 | 209 | 0.120 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2023 | 1726 | 0.120 |
Why?
|
Protein Stability | 2 | 2024 | 579 | 0.120 |
Why?
|
Adult | 23 | 2024 | 221119 | 0.120 |
Why?
|
Neoplasm Metastasis | 7 | 2021 | 4909 | 0.120 |
Why?
|
Transcription, Genetic | 5 | 2008 | 7571 | 0.120 |
Why?
|
Pancreatic Neoplasms | 2 | 2023 | 5366 | 0.120 |
Why?
|
MicroRNAs | 2 | 2024 | 3758 | 0.110 |
Why?
|
RNA, Small Interfering | 3 | 2020 | 3412 | 0.110 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13632 | 0.110 |
Why?
|
Homozygote | 1 | 1999 | 1775 | 0.110 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2016 | 736 | 0.110 |
Why?
|
Drug Synergism | 2 | 2021 | 1756 | 0.110 |
Why?
|
DNA, Neoplasm | 2 | 2016 | 1743 | 0.110 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1553 | 0.110 |
Why?
|
rab GTP-Binding Proteins | 1 | 2015 | 245 | 0.110 |
Why?
|
Disease Models, Animal | 5 | 2020 | 18220 | 0.110 |
Why?
|
ras Proteins | 3 | 2004 | 1055 | 0.110 |
Why?
|
Androgens | 1 | 2020 | 1283 | 0.110 |
Why?
|
Proto-Oncogenes | 1 | 1993 | 321 | 0.110 |
Why?
|
Immunoblotting | 1 | 2016 | 1644 | 0.100 |
Why?
|
Mice, Inbred C57BL | 7 | 2021 | 22127 | 0.100 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2020 | 1624 | 0.100 |
Why?
|
Middle Aged | 22 | 2024 | 220853 | 0.100 |
Why?
|
Cytosol | 1 | 2016 | 883 | 0.100 |
Why?
|
Forkhead Transcription Factors | 1 | 2019 | 1613 | 0.100 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1900 | 0.100 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2016 | 487 | 0.100 |
Why?
|
Transplantation, Heterologous | 2 | 2021 | 2381 | 0.100 |
Why?
|
Pyrimidines | 1 | 2024 | 3027 | 0.100 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 872 | 0.100 |
Why?
|
Pyruvate Kinase | 1 | 2013 | 189 | 0.100 |
Why?
|
Phenotype | 5 | 2022 | 16575 | 0.100 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2001 | 1074 | 0.100 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3873 | 0.100 |
Why?
|
Mammary Tumor Virus, Mouse | 1 | 2011 | 41 | 0.090 |
Why?
|
Estradiol | 1 | 2018 | 1937 | 0.090 |
Why?
|
Quinazolines | 2 | 2024 | 1371 | 0.090 |
Why?
|
Virus Replication | 1 | 2019 | 2426 | 0.090 |
Why?
|
Epidermal Growth Factor | 2 | 2011 | 699 | 0.090 |
Why?
|
Telomeric Repeat Binding Protein 1 | 2 | 2008 | 7 | 0.090 |
Why?
|
Neoplasm Transplantation | 4 | 2017 | 2010 | 0.090 |
Why?
|
DNA Repair | 1 | 2020 | 2041 | 0.090 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3770 | 0.090 |
Why?
|
Cytoskeleton | 1 | 2016 | 1169 | 0.090 |
Why?
|
beta Catenin | 3 | 2006 | 1042 | 0.090 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2011 | 117 | 0.090 |
Why?
|
RNA, Neoplasm | 2 | 2009 | 748 | 0.090 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2011 | 77 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3840 | 0.090 |
Why?
|
Hematopoiesis | 3 | 1994 | 2046 | 0.090 |
Why?
|
Mice, Nude | 3 | 2021 | 3605 | 0.090 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2813 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1112 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3594 | 0.080 |
Why?
|
Neoplastic Stem Cells | 2 | 2015 | 1348 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2016 | 2058 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 2 | 2008 | 1967 | 0.080 |
Why?
|
Venous Thrombosis | 1 | 1999 | 1304 | 0.080 |
Why?
|
Aged | 17 | 2023 | 169288 | 0.080 |
Why?
|
DNA, Viral | 1 | 2016 | 2195 | 0.080 |
Why?
|
Cluster Analysis | 1 | 2016 | 2706 | 0.080 |
Why?
|
Telomere | 2 | 2008 | 939 | 0.080 |
Why?
|
Drug Resistance | 2 | 1994 | 1594 | 0.080 |
Why?
|
Survival Rate | 5 | 2021 | 12728 | 0.080 |
Why?
|
Immunotherapy | 2 | 2021 | 4642 | 0.080 |
Why?
|
DNA-Binding Proteins | 5 | 2009 | 9566 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1662 | 0.080 |
Why?
|
Genes, p53 | 1 | 2011 | 713 | 0.080 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2009 | 146 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2003 | 1168 | 0.080 |
Why?
|
Amino Acid Motifs | 4 | 2021 | 924 | 0.080 |
Why?
|
Phosphothreonine | 2 | 2005 | 62 | 0.070 |
Why?
|
Germ-Line Mutation | 3 | 2023 | 1852 | 0.070 |
Why?
|
Isomerism | 2 | 2005 | 197 | 0.070 |
Why?
|
Asthenozoospermia | 1 | 2007 | 6 | 0.070 |
Why?
|
Logistic Models | 1 | 2022 | 13249 | 0.070 |
Why?
|
Alzheimer Disease | 4 | 2006 | 8603 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 3 | 1994 | 3388 | 0.070 |
Why?
|
Cytoskeletal Proteins | 2 | 2003 | 1334 | 0.070 |
Why?
|
Hodgkin Disease | 3 | 1998 | 1379 | 0.070 |
Why?
|
Body Mass Index | 1 | 2024 | 12952 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2019 | 3551 | 0.070 |
Why?
|
Apoptosis | 5 | 2024 | 9477 | 0.070 |
Why?
|
Receptors, Progesterone | 2 | 2021 | 1129 | 0.070 |
Why?
|
Organoids | 2 | 2023 | 744 | 0.070 |
Why?
|
Membrane Proteins | 3 | 2019 | 7851 | 0.060 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5478 | 0.060 |
Why?
|
Etoposide | 4 | 2019 | 635 | 0.060 |
Why?
|
Androgen Receptor Antagonists | 1 | 2006 | 125 | 0.060 |
Why?
|
Phosphoserine | 1 | 2005 | 203 | 0.060 |
Why?
|
Sexual Abstinence | 1 | 2004 | 17 | 0.060 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1089 | 0.060 |
Why?
|
Mice, Transgenic | 4 | 2020 | 9520 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 1994 | 3696 | 0.050 |
Why?
|
Testis | 1 | 2007 | 781 | 0.050 |
Why?
|
Down-Regulation | 2 | 2008 | 2916 | 0.050 |
Why?
|
Protein Binding | 7 | 2020 | 9297 | 0.050 |
Why?
|
Keratin-7 | 1 | 2023 | 55 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2011 | 9187 | 0.050 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2019 | 3609 | 0.050 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1994 | 1640 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 2 | 2002 | 4513 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2003 | 4935 | 0.050 |
Why?
|
Spermatozoa | 1 | 2007 | 630 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2020 | 1602 | 0.050 |
Why?
|
Trans-Activators | 2 | 2003 | 2846 | 0.050 |
Why?
|
Prospective Studies | 3 | 2022 | 54435 | 0.050 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2021 | 17 | 0.050 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2024 | 330 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3702 | 0.050 |
Why?
|
Lactates | 1 | 2022 | 401 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2002 | 361 | 0.050 |
Why?
|
Reference Values | 1 | 2009 | 4921 | 0.050 |
Why?
|
6-Aminonicotinamide | 1 | 2021 | 8 | 0.050 |
Why?
|
Bicarbonates | 1 | 2022 | 292 | 0.050 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2021 | 80 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6588 | 0.050 |
Why?
|
Male | 16 | 2024 | 360693 | 0.050 |
Why?
|
Mastectomy | 2 | 2020 | 1818 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2011 | 0.050 |
Why?
|
Rodentia | 1 | 2022 | 261 | 0.050 |
Why?
|
Ki-67 Antigen | 1 | 2023 | 628 | 0.040 |
Why?
|
Doxorubicin | 4 | 2020 | 2224 | 0.040 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2006 | 1111 | 0.040 |
Why?
|
Genes, BRCA2 | 1 | 2023 | 591 | 0.040 |
Why?
|
Adolescent | 6 | 2022 | 88298 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2023 | 9278 | 0.040 |
Why?
|
Molecular Sequence Data | 7 | 2013 | 17598 | 0.040 |
Why?
|
Alanine | 1 | 2022 | 608 | 0.040 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2001 | 219 | 0.040 |
Why?
|
Gene Expression | 4 | 2006 | 7571 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1150 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 438 | 0.040 |
Why?
|
Granzymes | 1 | 2021 | 276 | 0.040 |
Why?
|
Young Adult | 3 | 2022 | 59221 | 0.040 |
Why?
|
Blood Coagulation Factor Inhibitors | 1 | 1999 | 14 | 0.040 |
Why?
|
Phosphatidylinositols | 1 | 2020 | 281 | 0.040 |
Why?
|
Idarubicin | 1 | 2019 | 59 | 0.040 |
Why?
|
Taxoids | 1 | 2022 | 668 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10756 | 0.040 |
Why?
|
Listeria monocytogenes | 1 | 2021 | 247 | 0.040 |
Why?
|
Treatment Outcome | 9 | 2021 | 64681 | 0.040 |
Why?
|
Drug Resistance, Multiple | 1 | 2020 | 255 | 0.040 |
Why?
|
Fibroblasts | 3 | 2023 | 4137 | 0.040 |
Why?
|
Symporters | 1 | 2021 | 363 | 0.040 |
Why?
|
Superoxide Dismutase | 1 | 2021 | 593 | 0.040 |
Why?
|
Base Sequence | 5 | 2013 | 12404 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2019 | 340 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 734 | 0.040 |
Why?
|
Nuclear Family | 1 | 1999 | 311 | 0.040 |
Why?
|
Blood Coagulation Tests | 1 | 1999 | 271 | 0.040 |
Why?
|
Models, Molecular | 3 | 2017 | 5406 | 0.040 |
Why?
|
Nucleotides | 1 | 2020 | 452 | 0.040 |
Why?
|
Sex Reassignment Surgery | 1 | 2020 | 164 | 0.040 |
Why?
|
Protein Conformation | 1 | 2005 | 3933 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2017 | 205 | 0.040 |
Why?
|
Genome, Human | 2 | 2021 | 4423 | 0.040 |
Why?
|
Azacitidine | 1 | 2019 | 336 | 0.040 |
Why?
|
Endocytosis | 1 | 2021 | 950 | 0.030 |
Why?
|
Deoxycytidine | 1 | 2021 | 878 | 0.030 |
Why?
|
Thiophenes | 1 | 2021 | 569 | 0.030 |
Why?
|
Protein Structure, Tertiary | 4 | 2006 | 3778 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13385 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 2 | 1998 | 1784 | 0.030 |
Why?
|
Chromosomal Instability | 2 | 2008 | 178 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 212 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2019 | 883 | 0.030 |
Why?
|
Inflammation | 1 | 2016 | 10759 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2001 | 1240 | 0.030 |
Why?
|
Antithrombins | 1 | 1999 | 294 | 0.030 |
Why?
|
Transfection | 4 | 2006 | 5748 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2022 | 1988 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1130 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2020 | 620 | 0.030 |
Why?
|
Saphenous Vein | 1 | 1999 | 516 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2021 | 1251 | 0.030 |
Why?
|
Lysosomes | 1 | 2021 | 921 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2021 | 1149 | 0.030 |
Why?
|
Homocysteine | 1 | 1999 | 637 | 0.030 |
Why?
|
Pyridones | 1 | 2021 | 809 | 0.030 |
Why?
|
Genomic Instability | 1 | 2020 | 709 | 0.030 |
Why?
|
RNA, Messenger | 4 | 1994 | 12747 | 0.030 |
Why?
|
Oncogenes | 1 | 2021 | 1220 | 0.030 |
Why?
|
Carcinoma in Situ | 1 | 2001 | 791 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3264 | 0.030 |
Why?
|
Survival Analysis | 2 | 2021 | 10088 | 0.030 |
Why?
|
Bone Marrow Cells | 2 | 2001 | 2410 | 0.030 |
Why?
|
NF-kappa B | 1 | 2003 | 2475 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2022 | 36415 | 0.030 |
Why?
|
Data Mining | 1 | 2020 | 554 | 0.030 |
Why?
|
Estrogens | 1 | 2021 | 1522 | 0.030 |
Why?
|
Procarbazine | 3 | 1998 | 172 | 0.030 |
Why?
|
Phenanthrolines | 1 | 2014 | 49 | 0.030 |
Why?
|
Ascites | 1 | 2016 | 338 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2017 | 1751 | 0.030 |
Why?
|
Cell Line | 5 | 2011 | 15545 | 0.030 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2016 | 330 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2020 | 2082 | 0.030 |
Why?
|
Equipment Design | 1 | 2022 | 3510 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 4 | 2007 | 3726 | 0.030 |
Why?
|
CA-125 Antigen | 1 | 2016 | 281 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2021 | 2897 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 982 | 0.030 |
Why?
|
Cisplatin | 1 | 2020 | 1652 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2022 | 2513 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 1993 | 91 | 0.030 |
Why?
|
Child | 1 | 2022 | 80152 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2003 | 2871 | 0.030 |
Why?
|
RNA, Antisense | 1 | 1993 | 136 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2001 | 11856 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2002 | 5773 | 0.030 |
Why?
|
Genes, Lethal | 1 | 2013 | 223 | 0.030 |
Why?
|
Bleomycin | 3 | 1998 | 495 | 0.030 |
Why?
|
CHO Cells | 2 | 2006 | 1379 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 961 | 0.030 |
Why?
|
Cell Respiration | 1 | 2013 | 201 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 2 | 2011 | 1111 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1994 | 704 | 0.030 |
Why?
|
Epithelium | 1 | 2017 | 1603 | 0.030 |
Why?
|
Mutagenesis | 2 | 2013 | 1226 | 0.030 |
Why?
|
Gene Silencing | 1 | 2019 | 1495 | 0.030 |
Why?
|
Amyloid beta-Peptides | 1 | 2006 | 3840 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2709 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2020 | 58952 | 0.030 |
Why?
|
Cricetinae | 2 | 2006 | 2412 | 0.030 |
Why?
|
Heterozygote | 1 | 1999 | 2778 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2020 | 80674 | 0.020 |
Why?
|
Prostatic Neoplasms | 2 | 2006 | 11101 | 0.020 |
Why?
|
Cell Membrane | 1 | 2021 | 3661 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3512 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2017 | 1186 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2014 | 900 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4111 | 0.020 |
Why?
|
Metabolome | 1 | 2017 | 989 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2013 | 801 | 0.020 |
Why?
|
Warfarin | 1 | 1999 | 1482 | 0.020 |
Why?
|
Cytokines | 2 | 2021 | 7386 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 1994 | 2468 | 0.020 |
Why?
|
Genes, Reporter | 2 | 2006 | 1518 | 0.020 |
Why?
|
Aging | 1 | 2008 | 8702 | 0.020 |
Why?
|
Prednisone | 3 | 1998 | 1565 | 0.020 |
Why?
|
DNA Primers | 1 | 1993 | 2814 | 0.020 |
Why?
|
Transcription Factors | 2 | 2002 | 12099 | 0.020 |
Why?
|
Nuclear Receptor Co-Repressor 2 | 1 | 2009 | 33 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1893 | 0.020 |
Why?
|
Verapamil | 1 | 1989 | 242 | 0.020 |
Why?
|
RNA Splicing | 1 | 2013 | 896 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2020 | 2827 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11119 | 0.020 |
Why?
|
tau Proteins | 1 | 1999 | 2094 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 1993 | 946 | 0.020 |
Why?
|
Cyclophosphamide | 3 | 1998 | 2219 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2507 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2002 | 5782 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2013 | 1668 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3620 | 0.020 |
Why?
|
Exons | 1 | 2013 | 2380 | 0.020 |
Why?
|
Proteome | 1 | 2017 | 1856 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2803 | 0.020 |
Why?
|
Acrosome Reaction | 1 | 2007 | 7 | 0.020 |
Why?
|
Sperm Head | 1 | 2007 | 8 | 0.020 |
Why?
|
Litter Size | 1 | 2007 | 49 | 0.020 |
Why?
|
Amino Acid Sequence | 4 | 2001 | 13402 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3634 | 0.020 |
Why?
|
Vinblastine | 2 | 1998 | 488 | 0.020 |
Why?
|
Rats | 1 | 2022 | 23704 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3590 | 0.020 |
Why?
|
Risk Factors | 2 | 2012 | 74239 | 0.020 |
Why?
|
Spermatogenesis | 1 | 2007 | 257 | 0.020 |
Why?
|
Computational Biology | 1 | 2017 | 3499 | 0.020 |
Why?
|
TCF Transcription Factors | 1 | 2006 | 138 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5828 | 0.020 |
Why?
|
Interphase | 1 | 2006 | 227 | 0.020 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2006 | 152 | 0.020 |
Why?
|
Threonine | 1 | 2006 | 270 | 0.020 |
Why?
|
Dacarbazine | 2 | 1998 | 559 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6199 | 0.020 |
Why?
|
HeLa Cells | 2 | 2001 | 3073 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2011 | 1264 | 0.010 |
Why?
|
NIH 3T3 Cells | 1 | 2006 | 667 | 0.010 |
Why?
|
Cricetulus | 1 | 2006 | 812 | 0.010 |
Why?
|
Luciferases | 1 | 2006 | 710 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6341 | 0.010 |
Why?
|
Telomerase | 1 | 2008 | 741 | 0.010 |
Why?
|
Cell Communication | 1 | 2011 | 1651 | 0.010 |
Why?
|
I-kappa B Proteins | 1 | 2003 | 210 | 0.010 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2003 | 178 | 0.010 |
Why?
|
Binding Sites | 2 | 2003 | 5988 | 0.010 |
Why?
|
Transcription Factor RelA | 1 | 2003 | 254 | 0.010 |
Why?
|
I-kappa B Kinase | 1 | 2003 | 249 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39126 | 0.010 |
Why?
|
Prognosis | 2 | 2018 | 29687 | 0.010 |
Why?
|
Aneuploidy | 1 | 2006 | 555 | 0.010 |
Why?
|
E2F Transcription Factors | 1 | 2002 | 269 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2007 | 2062 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2002 | 864 | 0.010 |
Why?
|
Lung | 1 | 2019 | 9979 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6486 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2001 | 6504 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2011 | 5871 | 0.010 |
Why?
|
Protein Subunits | 1 | 2003 | 940 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2002 | 367 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2002 | 850 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2006 | 1077 | 0.010 |
Why?
|
DNA | 1 | 1993 | 7189 | 0.010 |
Why?
|
Czech Republic | 1 | 1998 | 74 | 0.010 |
Why?
|
Filgrastim | 1 | 1998 | 132 | 0.010 |
Why?
|
Caspase 3 | 1 | 2001 | 730 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2016 | 10203 | 0.010 |
Why?
|
Austria | 1 | 1998 | 206 | 0.010 |
Why?
|
Brain | 2 | 2022 | 27092 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2001 | 1681 | 0.010 |
Why?
|
Switzerland | 1 | 1998 | 319 | 0.010 |
Why?
|
Caspases | 1 | 2001 | 878 | 0.010 |
Why?
|
Leukemia | 2 | 1998 | 1518 | 0.010 |
Why?
|
Xenopus | 1 | 1999 | 709 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 1999 | 564 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2001 | 1737 | 0.010 |
Why?
|
Cadherins | 1 | 2001 | 902 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15920 | 0.010 |
Why?
|
Germany | 1 | 1998 | 872 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 1998 | 629 | 0.010 |
Why?
|
Protein Transport | 1 | 2001 | 1958 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1999 | 1768 | 0.010 |
Why?
|
Prostatectomy | 1 | 2003 | 1825 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2001 | 3577 | 0.010 |
Why?
|
Retroviridae Proteins, Oncogenic | 1 | 1994 | 74 | 0.010 |
Why?
|
Cell Movement | 1 | 2007 | 5195 | 0.010 |
Why?
|
Thionucleotides | 1 | 1994 | 107 | 0.010 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 1 | 1994 | 195 | 0.010 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 1994 | 94 | 0.010 |
Why?
|
Colony-Forming Units Assay | 1 | 1994 | 351 | 0.010 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 1994 | 186 | 0.010 |
Why?
|
Kinetics | 1 | 2001 | 6312 | 0.010 |
Why?
|
Guanosine Diphosphate | 1 | 1993 | 79 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1994 | 1140 | 0.010 |
Why?
|
Remission Induction | 1 | 1998 | 2392 | 0.010 |
Why?
|
Leukemia, Experimental | 1 | 1993 | 225 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2001 | 2881 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 1994 | 655 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1993 | 818 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 1989 | 5145 | 0.010 |
Why?
|
Neoplasms, Second Primary | 1 | 1998 | 1052 | 0.010 |
Why?
|
Phosphoproteins | 1 | 1999 | 2444 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1998 | 4851 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1993 | 2740 | 0.000 |
Why?
|
Cytarabine | 1 | 1989 | 697 | 0.000 |
Why?
|
Cloning, Molecular | 1 | 1993 | 4167 | 0.000 |
Why?
|
Cattle | 1 | 1993 | 3818 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2003 | 8998 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1998 | 8519 | 0.000 |
Why?
|
United States | 1 | 2012 | 72339 | 0.000 |
Why?
|
Antigens, CD | 1 | 1994 | 4009 | 0.000 |
Why?
|
Dexamethasone | 1 | 1989 | 1945 | 0.000 |
Why?
|
Disease Progression | 1 | 1998 | 13511 | 0.000 |
Why?
|
Cohort Studies | 1 | 2003 | 41496 | 0.000 |
Why?
|